Topic: AML treatment options

Objectives: Discuss incorporating Gilteritinib and Quizartinib

Speaker: Dr. Liz Cull, Dr. Bhumika Patel

 

Session date: 
09/25/2024 - 8:00am to 9:00am EDT
Location: 
GMH Support Tower 41/Teams
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    The University of South Carolina School of Medicine Greenville designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The University of South Carolina School of Medicine Greenville is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance

Please login or register to take this course.